Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Nanologica

1.04

 

SEK

 

-5.88 %

Less than 1K followers

NICA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
-5.88%
-15.45%
-44.09%
-42.86%
-38.82%
-83.17%
-92.62%
-91.12%
-94.27%

Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.

Read more
Market cap
91.9M SEK
Turnover
172.34K SEK
Revenue
14.54M
EBIT %
-407.57 %
P/E
-
Dividend yield-%
-
Financial calendar
10/7
2025

Interim report Q2'25

23/10
2025

Interim report Q3'25

6/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Regulatory press release5/23/2025, 2:41 PM

Nanologica AB (publ) meddelar utfall av inlösen av teckningsoptioner av serie TO5

Nanologica
Regulatory press release5/23/2025, 2:41 PM

Nanologica AB (publ) Announces the Outcome of the Exercise of Warrants of Series TO5

Nanologica
Regulatory press release5/23/2025, 5:36 AM

Kommentar från styrelsen i Nanologica AB (publ) angående budpliktsbud från Flerie Invest AB

Nanologica

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/23/2025, 5:36 AM

Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from Flerie Invest AB

Nanologica
Regulatory press release5/22/2025, 12:54 PM

Kommuniké årsstämma 2025 Nanologica AB (publ)

Nanologica
Regulatory press release5/22/2025, 12:54 PM

Bulletin from the AGM 2025 Nanologica AB (publ)

Nanologica
Press release4/26/2025, 9:42 AM

Nanologica AB informerar om att Flerie Invest AB har passerat gränsen för budplikt

Nanologica
Press release4/26/2025, 9:42 AM

Nanologica AB Informs that Flerie Invest AB has Passed the Threshold for Mandatory Bid

Nanologica
Press release4/24/2025, 11:36 AM

Redeye: Nanologica Q1 2025 - Limited near-term visibility but sales ramp up to be expected in H2

Nanologica
Regulatory press release4/23/2025, 5:06 AM

Nanologica AB tar order om 180 000 USD från ny kund i Kina

Nanologica
Regulatory press release4/23/2025, 5:06 AM

Nanologica AB Receives Order Worth USD 180,000 from New Customer in China

Nanologica
Regulatory press release4/16/2025, 3:35 PM

KALLELSE TILL ÅRSSTÄMMA I NANOLOGICA AB (PUBL)

Nanologica
Regulatory press release4/16/2025, 3:35 PM

NOTICE CONVENING THE ANNUAL GENERAL MEETING OF NANOLOGICA AB (PUBL)

Nanologica
Regulatory press release4/16/2025, 6:12 AM

Delårsrapport Q1 2025 Nanologica AB (publ)

Nanologica
Regulatory press release4/16/2025, 6:12 AM

Interim Report Q1 2025 Nanologica AB (publ)

Nanologica
Regulatory press release4/15/2025, 3:35 PM

NANOLOGICA AB ÄNDRAR DATUM FÖR DELÅRSRAPPORT

Nanologica
Regulatory press release4/15/2025, 3:35 PM

NANOLOGICA AB CHANGES DATES FOR INTERIM REPORT

Nanologica
Regulatory press release3/28/2025, 7:05 AM

Nanologica AB publicerar årsredovisning för 2024

Nanologica
Regulatory press release3/28/2025, 7:05 AM

Nanologica AB Publishes the Annual Report 2024

Nanologica
Press release3/24/2025, 1:17 PM

Nanologica AB förlänger befintligt lån från Flerie Invest AB

Nanologica
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team